We are live on ! Find out more
SIG

Sargent Investment Group Portfolio holdings

AUM $759M
1-Year Est. Return 28.58%
This Fund
S&P 500
This Quarter Est. Return
-1.58%
1 Year Est. Return
+28.58%
3 Year Est. Return
+104.74%
5 Year Est. Return
+107.13%
10 Year Est. Return
–
AUM
$626M
AUM Growth
+$14.7M
Cap. Flow
+$25.5M
Cap. Flow %
4.08%
Top 10 Hldgs %
41.12%
Holding
250
New
14
Increased
124
Reduced
72
Closed
16

Top Buys

Rank Stock Value
1
PLTR icon
Palantir
PLTR
+$4.84M
2
KO icon
Coca-Cola
KO
+$3.23M
3
UITB icon
Victory Portfolios II VictoryShares Core Intermediate Bond ETF
UITB
+$2.99M
4
BILS icon
State Street SPDR Bloomberg 3-12 Month T-Bill ETF
BILS
+$2.89M
5
UBER icon
Uber
UBER
+$1.71M

Top Sells

Rank Stock Value
1
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
+$4.69M
2
SPYG icon
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
+$1.48M
3
SMMT icon
Summit Therapeutics
SMMT
+$1.4M
4
ERII icon
Energy Recovery
ERII
+$1.33M
5
ACHR icon
Archer Aviation
ACHR
+$1.15M

Sector Composition

Rank Sector Weight
1 Technology 28.09%
2 Financials 12.52%
3 Healthcare 7.86%
4 Industrials 4.94%
5 Consumer Discretionary 4.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
THW
226
abrdn World Healthcare Fund
THW
$551M
$115K 0.02%
10,000
– –
RIG icon
227
Transocean
RIG
$5.82B
$71.3K 0.01%
22,500
-155
-0.7% -$544
LUCD icon
228
Lucid Diagnostics
LUCD
$184M
$64.8K 0.01%
43,500
-498,000
-92% -$598K
CX icon
229
Cemex
CX
$16.3B
$61.7K 0.01%
+11,000
New +$66.5K
WULF icon
230
TeraWulf
WULF
$8.52B
$55.2K 0.01%
20,225
-197,615
-91% -$880K
MTNB icon
231
Matinas BioPharma
MTNB
$1.81M
$21.7K ﹤0.01%
41,800
-22,400
-35% -$13.3K
CHRS icon
232
Coherus Oncology
CHRS
$196M
$13.5K ﹤0.01%
16,670
-7,615
-31% -$8.76K
OPTT icon
233
Ocean Power Technologies
OPTT
$49.9M
$12.8K ﹤0.01%
28,000
-500,000
-95% -$360K
LONA
234
LeonaBio Inc
LONA
$72.1M
– –
-1,092
Closed -$5.8K
BA icon
235
Boeing
BA
$185B
– –
-1,256
Closed -$214K
CCL icon
236
Carnival Corporation Ltd
CCL
$39.7B
– –
-32,896
Closed -$786K
CHDN icon
237
Churchill Downs
CHDN
$6.12B
– –
-1,790
Closed -$229K
DEA
238
Easterly Government Properties
DEA
$1.18B
– –
-8,426
Closed -$238K
LILAK icon
239
Liberty Latin America Class C
LILAK
$1.64B
– –
-12,183
Closed -$68.9K
NRDY icon
240
Nerdy
NRDY
$96.7M
– –
-100,000
Closed -$153K
NVAX icon
241
Novavax
NVAX
$1.31B
– –
-50,775
Closed -$437K
OM icon
242
Outset Medical
OM
$90.8M
– –
-945
Closed -$11.4K
RLMD icon
243
Relmada Therapeutics
RLMD
$527M
– –
-11,670
Closed -$4.71K
RXT icon
244
Rackspace Technology
RXT
$1.24B
– –
-20,150
Closed -$46.7K
TARS icon
245
Tarsus Pharmaceuticals
TARS
$2.84B
– –
-4,465
Closed -$210K
TEVA icon
246
CALL
Teva Pharmaceuticals
TEVA
$41.2B
– –
0
– -$54K
VOE icon
247
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24B
– –
-1,963
Closed -$315K
WH icon
248
Wyndham Hotels & Resorts
WH
$5.48B
– –
-2,020
Closed -$204K
XYZ
249
Block Inc
XYZ
$47.5B
– –
-3,649
Closed -$299K
CDMO
250
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
– –
-377,694
Closed -$4.69M
6 7 8 9
10

Similar funds

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
TVAMP
Tennessee Valley Asset Management Partners Knoxville, Tennessee $757M AUM 14.19% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
MWA
Meridian Wealth Advisors Austin, Texas $756M AUM 21.36% 1-Year Est. Return
GWM
Gibbs Wealth Management Alpharetta, Georgia $762M AUM 18.55% 1-Year Est. Return
TI
Think Investments San Francisco, California $762M AUM 33.1% 1-Year Est. Return
JGUA
John G. Ullman & Associates Corning, New York $754M AUM 60.05% 1-Year Est. Return
HCM
HMI Capital Management San Francisco, California $754M AUM 23.78% 1-Year Est. Return

Sargent Investment Group's Q1 2025 Portfolio in Review

As of Q1 2025, Sargent Investment Group held 250 positions worth $626M, up 2.4% from $611M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Sargent Investment Group deployed $25.5M of net new capital in Q1 2025, opening 14 new positions and adding to 124 existing holdings. Its largest new stake was DexCom: 13,265 shares worth $906K.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR Portfolio S&P 500 Growth ETF, an estimated $1.48M trimmed.

  • Sargent Investment Group's largest Q1 2025 buy was DexCom: 13,265 shares worth $906K.
  • Sargent Investment Group added most to Palantir in Q1 2025, an estimated $4.84M increase.
  • Sargent Investment Group's biggest Q1 2025 reduction was State Street SPDR Portfolio S&P 500 Growth ETF, cutting an estimated $1.48M.
  • Sargent Investment Group fully exited Avid Bioservices, Inc. Common Stock in Q1 2025, selling an estimated $4.69M.
  • Sargent Investment Group's ten largest holdings make up 41% of its $626M portfolio in Q1 2025.
  • Sargent Investment Group opened 14 new positions and closed 16 in Q1 2025.
  • Sargent Investment Group's portfolio value rose 2.4% quarter-over-quarter to $626M.

Based on Sargent Investment Group's 13F filing for Q1 2025, filed 5 May 2025.